跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NICABATE MINI LOZENGES nicotine 4 mg (as polacrilex) mint flavour lozenge tube (new formulation) - TGA Drug Approval Details
Approvals
/
TGA
/
NICABATE MINI LOZENGES nicotine 4 mg (as polacrilex) mint flavour lozenge tube (new formulation)
Approved
STANDARD
NICABATE MINI LOZENGES nicotine 4 mg (as polacrilex) mint flavour lozenge tube (new formulation)
Haleon Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
ca54692fca64aa67
Company
Haleon Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
ca54692fca64aa67
Product Name
NICABATE MINI LOZENGES nicotine 4 mg (as polacrilex) mint flavour lozenge tube (new formulation)
Artg Id
392046
Artg Name
NICABATE MINI LOZENGES nicotine 4 mg (as polacrilex) mint flavour lozenge tube (new formulation)
Sponsor
Haleon Australia Pty Ltd
Company Detail Path
/organization/haleon-australia-pty-ltd
Artg Date
2022-07-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/e2043192455cbe817c2bcb010b726532.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
ca54692fca64aa67
Type
Standard
Back to TGA Approvals